Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area-Reference-Cited by-同舟云学术

Visceral leishmaniasis complicated by hemophagocytic lymphohistiocytosis: A case report from a nonendemic area

Published:2023-05 Issue:5 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Joudeh Anwar I.¹^ORCID,Elsiddig Awadelkarim Hussein A.¹,Gul Mohammadshah Isam²,Elayana Mahmoud Salm²,Soliman Dina Sameh³,Amer Aliaa³,Alsamawi Musaed⁴

Affiliation:

1. Department of Internal Medicine, Al‐Khor Hospital Hamad Medical Corporation Doha Qatar

2. Department of Internal Medicine, Hamad General Hospital Hamad Medical Corporation Doha Qatar

3. Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar

4. Department of Internal Medicine, Infectious Diseases Division, Al‐Khor Hospital Hamad Medical Corporation Doha Qatar

Abstract

Key Clinical MessageVisceral leishmaniasis and hemophagocytic lymphohistiocytosis share many features in common and may coincide in the same patient. Timely diagnosis and management of visceral leishmaniasis could save patients from unnecessary toxic treatment.AbstractVisceral leishmaniasis and hemophagocytic lymphohistiocytosis share many clinical features in common and may coexist in the same patient. Visceral leishmaniasis should be promptly ruled out in patients coming from endemic areas before starting immunosuppressive therapy for hemophagocytic lymphohistiocytosis. The mainstay treatment, in this case, is anti‐leishmania medications preferably liposomal amphotericin‐B.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7309

Reference15 articles.

1. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

2. The world's most neglected diseases

3. World Health Organization. Leishmaniasis in high‐burden countries: an epidemiological update based on data reported in 2014. Who.int.https://www.who.int/publications/i/item/who‐wer9122. Published 2016.

4. Histiocytic Disorders: Recent Insights into Pathophysiology and Practical Guidelines

5. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation